Patterns and correlates of alcohol use amongst heroin users: 11-year follow-up of the Australian Treatment Outcome Study cohort

Addictive Behaviors

Volumn 50, Issue , 2015, Pages 78-83

  Darke, Shane ^a   Slade, Tim ^a,b   Ross, Joanne ^a,b   Marel, Christina ^a,b   Mills, Katherine L ^a,b   Tessson, Maree ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NHMRC Centre for Research Excellence in Mental Health and Substances Use   (Australia)

Author keywords

Alcohol; ATOS; Cohort; Harm; Heroin

Indexed keywords

DIAMORPHINE;

ADULT; AGED; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ARTICLE; COHORT ANALYSIS; CRIMINAL BEHAVIOR; DRINKING BEHAVIOR; DRUG USE; FEMALE; FOLLOW UP; HEALTH STATUS; HEROIN DEPENDENCE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; SHORT FORM 12; STRUCTURED INTERVIEW; ALCOHOL-RELATED DISORDERS; AUSTRALIA; COMORBIDITY; CRIME; DRUG OVERDOSE; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ADULT; AGED; ALCOHOL ABSTINENCE; ALCOHOL DRINKING; ALCOHOL-RELATED DISORDERS; AUSTRALIA; COHORT STUDIES; COMORBIDITY; CRIME; DRUG OVERDOSE; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HEROIN DEPENDENCE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84934888395     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2015.06.030     Document Type: Article

References (46)

1. Abelson J., Treloar C., Crawford J., Kippax S., Van Beek I., Howard J. Some characteristics of early-onset injection drug users prior to and at the time of their first injection. Addiction 2006, 101:548-555.
2. Australian Institute of Health and Welfare 2010 National Drug Strategy Household Survey. Drug Statistics Series 2011, 25. AIHW, Canberra.
3. Brugal M.T., Barrio G., de la Fuente L., Regidor E., Royuela L., Suelves J.M. Factors associated with non-fatal heroin overdose: Assessing the effect of frequency and route of heroin administration. Addiction 2002, 97:319-327.
4. Cacciola J.S., Alterman A.I., Rutherford M.J., McKay J.R., Mulvaney F.D. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug and Alcohol Dependence 2001, 61:271-280.
5. Caputo F., Addolorato G., Domenicali M., Mosti A., Viaggi M., Trevisani F., et al. Short-term methadone administration reduces alcohol consumption in non-alcoholic heroin addicts. Alcohol and Alcoholism 2002, 37:164-168.
6. Carpentier P.J., Krabbe P.F.M., van Gogh M.T., Knapen L.J.M., Buitelaar J.K., de Jong C.A.J. Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. American Journal on Addictions 2009, 18:470-480.
7. Coffin P.O., Galea S., Ahern J., Leon A.C., Vlahov D., Tardiff K. Opiate, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-1998. Addiction 2003, 98:739-747.
8. Coffin P.O., Tracy M., Bucciarelli A., Ompad D., Vlahov D., Galea S. Identifying injecting drug users at risk of nonfatal overdose. Academic Emergency Medicine 2007, 14:616-623.
9. Cranford J.A., Eisenberg D., Serras A.M. Substance use behaviors, mental health problems, and use of mental health services in a probability sample of college students. Addictive Behaviors 2009, 34:134-145.
10. Cui J. QIC program and model selection in GEE analysis. Stata Journal 2007, 7:209-220.
11. Darke S. The life of the heroin user: Typical beginnings, trajectories and outcomes 2011, Cambridge University Press, Cambridge.
12. Darke S., Duflou J., Torok M. The comparative toxicology and major organ pathology of fatal methadone and heroin toxicity cases. Drug and Alcohol Dependence 2010, 106:1-6.
13. Darke S., Duflou J., Torok M., Prolov T. Characteristics, circumstances and toxicology of sudden or unnatural deaths involving very high range alcohol concentrations. Addiction 2013, 108:1411-1417.
14. Darke S., Hall W., Heather N., Wodak A., Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opioid users, The Opiate Treatment Index. British Journal of Addiction 1992, 87:593-602.
15. Darke S., Heather N., Hall W., Ward J., Wodak A. Estimating drug consumption in opioid users: Reliability and validity of a "recent use" episodes method. British Journal of Addiction 1991, 86:1311-1316.
16. Darke S., Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug and Alcohol Dependence 1997, 48:135-141.
17. Darke S., Williamson A., Ross J., Teesson M. Reductions in heroin use are not associated with increases in other drug use: Two year findings from the Australian Treatment Outcome Study. Drug and Alcohol Dependence 2006, 84:201-205.
18. Dawson D.A., Grant B.F., Stinson F.S., Chou P.S. Psychopathology associated with drinking and alcohol use disorders in the college and general adult populations. Drug and Alcohol Dependence 2005, 77:139-150.
19. Fairbank J.A., Dunteman G.H., Condelli W.S. Do methadone patients substitute other drugs for heroin? Predicting substance use at 1-year follow-up. American Journal of Drug and Alcohol Abuse 1993, 19:465-474.
20. Gossop M., Marsden J., Stewart D., Kidd T. The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. Addiction 2003, 98:291-303.
21. Gossop M., Steward D., Treacy S., Marsden J. A prospective study of mortality among drug misusers during a four year period after seeking treatment. Addiction 2002, 97:39-47.
22. Hu F.B., Goldberg J., Hedeker D., Flay B.R., Pentz M.A. Comparison of population-averaged and subject-specific approaches for analyzing repeated binary outcomes. American Journal of Epidemiology 1998, 147:694-703.
23. Hubbard R.L., Craddock S.G., Flynn P.M., Anderson J., Etheridge R.M. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 1997, 11:261-278.
24. IBM SPSS inc. SPSS for Windows, 22.0 2013, SPSS inc., Chicago, IL.
25. Jackson C.T., Covell N.H., Frisman L.K., Essock S.M. Validity of self-reported drug use among people with co-occurring mental health and substance use disorders. Journal of Dual Diagnosis 2004, 1:49-63.
26. Karch S.B. Karch's pathology of drug abuse 2009, CRC Press, Boca Raton. 4th ed.
27. Kerr T., Fairbairn N., Tyndall M., Marsh D., Li K., Montaner J., et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug and Alcohol Dependence 2007, 87:39-45.
28. Kessler R.C., Berglund P., Demler O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey replication. Archives of General Psychiatry 2005, 62:593-602.
29. Kidorf M., Disney E.R., King V.L., Neufeld K., Beilenson P.L., Brooner R.K. Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program. Drug and Alcohol Dependence 2004, 74:115-122.
30. Maloney E., Degenhardt L., Darke S., Nelson E.C. Are non-fatal opioid overdoses misclassified suicide attempts? Comparing the associated correlates. Addictive Behaviors 2009, 34:723-729.
31. Marel C., Mills K.L., Darke S., Ross J., Slade T., Burns L., et al. Static and dynamic predictors of criminal involvement among people with heroin dependence: Findings from a 3-year longitudinal study. Drug and Alcohol Dependence 2013, 133:600-606.
32. McKeganey N., Bloor M., Robertson M., Neale J., MacDougall J. Abstinence and drug abuse treatment: Results from the Drug Outcome Research in Scotland study. Drugs: Education, Prevention, and Policy 2006, 13:537-550.
33. Napper L.E., Fisher D.G., Johnson M.E., Wood M.M. The reliability and validity of drug users' self reports of amphetamine use among primarily heroin and cocaine users. Addictive Behaviors 2010, 35:350-354.
34. National Health and Medical Research Council Australian guidelines to reduce health risks from drinking alcohol 2009, Commonwealth of Australia, Canberra.
35. Nelson P.K., Mathers B.M., Cowie B., Hagan H., Des Jarlais D., Horyniak D., et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews. Lancet 2011, 378:571-583.
36. Ompad D.C., Ikeda R.M., Shah N., Fuller C.M., Bailey S., Morse E., et al. Childhood sexual abuse and age at initiation of injection drug use. American Journal of Public Health 2005, 95:703-709.
37. Ramstedt M. Alcohol and suicide in 14 European countries. Addiction 2001, 96(Suppl. 1):S59-S75.
38. Ross J., Teesson M., Darke S., Lynskey M., Ali R., Ritter A., et al. The characteristics of heroin users entering treatment: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review 2005, 24:411-418.
39. Ross J., Teesson M., Darke S., Lynskey M., Ali R., Ritter A., et al. Short-term outcomes for the treatment of heroin dependence, findings from the Australian Treatment Outcome Study (ATOS). Addictive Disorders & Their Treatment 2006, 5:133-144.
40. Salamina G., Diecidue R., Vigna-Taglianti F., Jarre P., Schifano P., Bargagli A.M., et al. Effectiveness of therapies for heroin addiction in retaining patients in treatment: Results from the VEdeTTE Study. Substance Use & Misuse 2010, 45:2076-2092.
41. Stapleton R.D., Comiskey C.M. Alcohol usage and associated treatment outcomes for opiate users entering treatment in Ireland. Drug and Alcohol Dependence 2010, 107:56-61.
42. StataCorp Stata statistical software: Release 13 2013, StataCorp LP, College Station, TX.
43. Teesson M., Hall W., Slade T., Mills K.L., Grove R., Mewton L., et al. Prevalence and correlates of DSM-IV alcohol abuse and dependence in Australia: Findings from the 2007 National Survey of Mental Health and Wellbeing. Addiction 2010, 105:2085-2094.
44. Teesson M., Mills K.L., Ross J., Darke S., Williamson A., Havard A. The impact of treatment on 3year outcomes for heroin dependence: Findings from the Australian Treatment Outcome Study (ATOS). Addiction 2008, 103:80-88.
45. Ware J.E., Kosinski M., Keller S.D. A 12-item short-form health survey, construction of scales, and preliminary tests of reliability and validity. Medical Care 1996, 34:220-233.
46. Wells J.E., Browne O., Scott K.M., McGee M.A., Baxter J., Kokaua J. Prevalence, interference with life and severity of 12month DSM-IV disorders in Te Rau Hinengaro: The New Zealand Mental Health Survey. The Australian and New Zealand Journal of Psychiatry 2006, 40:845-854.